Condition: Metastatic Prostate Carcinoma


rs11017056 in C10orf143 gene and Metastatic Prostate Carcinoma PMID 27143689 2016 Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.

rs875858 in VAC14 gene and Metastatic Prostate Carcinoma PMID 27143689 2016 Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.